Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2Recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 10Gastrointestinal 9Thoracic 8Breast 6Lymphoid 3Head & Neck 3Sarcoma 2Other hematologic neoplasm 2CNS 2Tumor-Agnostic 1Other 1Dermatologic 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Gliosarcoma 1Glioblastoma 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Cyclophosphamide 26Temozolomide 23Doxorubicin 22Radiotherapy 21Filgrastim 19Ifosfamide 15pazopanib 14Gemcitabine 14Etoposide 13Bevacizumab 13Irinotecan 12Cisplatin 12Magnetic Resonance Spectroscopy 11Imatinib Mesylate 11Granulocyte Colony-Stimulating Factor 11Carboplatin 11Radiation 9Methotrexate 9pembrolizumab 8fludarabine phosphate 8Rituximab 8Paclitaxel 8Docetaxel 8Cyclosporine 8Busulfan 8Antilymphocyte Serum 8fludarabine 7Vincristine 7Radiotherapy, Intensity-Modulated 7Mycophenolic Acid 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Metformin × Sarcoma × Clear all
NCT01430351 2025-05-07

Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy

M.D. Anderson Cancer Center

Phase 1 Terminated
144 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT02531308 2022-09-28

DLBCL

Rush University Medical Center

Phase 2 Terminated
5 enrolled 5 charts
LymphoidSarcoma

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡